|
|
|
|
|
Home >> Investor Relations >> Corporate Governance >> Insider Transactions
Insider Transactions
Date  |
Name |
Title |
Type |
Shares Traded |
Price Range |
| Mar 5, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
12,008 |
9.64 - 9.75 |
| Mar 5, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
37,992 |
9.76 - 10.18 |
| Mar 5, 2008 |
topper james n |
Director |
Buy |
12,008 |
9.64 - 9.75 |
| Mar 5, 2008 |
topper james n |
Director |
Buy |
37,992 |
9.76 - 10.18 |
| Mar 4, 2008 |
crowley john f |
Officer |
Automatic Sell |
5,503 |
10.00 |
| Mar 4, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
4,500 |
9.60 - 9.84 |
| Mar 4, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
9,000 |
9.85 - 10.12 |
| Mar 4, 2008 |
topper james n |
Director |
Buy |
4,500 |
9.60 - 9.84 |
| Mar 4, 2008 |
topper james n |
Director |
Buy |
9,000 |
9.85 - 10.12 |
| Mar 3, 2008 |
crowley john f |
Officer |
Automatic Sell |
4,497 |
10.00 |
| Mar 3, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
43,674 |
9.51 - 9.82 |
| Mar 3, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
18,426 |
9.83 - 10.00 |
| Mar 3, 2008 |
topper james n |
Director |
Buy |
43,674 |
9.51 - 9.82 |
| Mar 3, 2008 |
topper james n |
Director |
Buy |
18,426 |
9.83 - 9825.00 |
| Mar 1, 2008 |
dentzer james e |
Officer |
Disposition (Non Open Market) |
220 |
9.85 |
| Feb 29, 2008 |
crowley john f |
Officer |
Option Execute |
10,000 |
0.64 |
| Feb 29, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
8,637 |
9.63 - 10.50 |
| Feb 29, 2008 |
topper james n |
Director |
Buy |
8,637 |
9.63 - 10.50 |
| Feb 28, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
2,038 |
9.84 - 9.96 |
| Feb 28, 2008 |
fhm iv lp |
Beneficial Owner (10% or more) |
Buy |
5,762 |
9.97 - 10.49 |
|
|
Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
|
|
|
|
|
|
|
